Financials IntelGenx Technologies Corp. Toronto S.E.

Equities

IGX

US45822R1014

Pharmaceuticals

End-of-day quote Toronto S.E. 06:00:00 2021-10-17 pm EDT 5-day change 1st Jan Change
0.78 CAD +9.86% Intraday chart for IntelGenx Technologies Corp. +50.00% +173.68%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 50.48 43.96 24.27 55.04 34.46 24.12
Enterprise Value (EV) 1 47.43 50.83 31.95 56.56 42.44 37.34
P/E ratio -3.96 x -4.12 x -3.39 x -5.25 x -2.82 x -2.43 x
Yield - - - - - -
Capitalization / Revenue 27.7 x 59.2 x 15.7 x 35.9 x 36.3 x 23.2 x
EV / Revenue 26 x 68.5 x 20.7 x 36.8 x 44.7 x 35.9 x
EV / EBITDA -5.73 x -5.76 x -5.78 x -7.87 x -4.91 x -4.28 x
EV / FCF -7.44 x -9.42 x -7.04 x -14.1 x -6.71 x -14.3 x
FCF Yield -13.4% -10.6% -14.2% -7.07% -14.9% -6.97%
Price to Book 5.05 x 151 x -25.7 x 14.2 x -10.1 x -1.97 x
Nbr of stocks (in thousands) 93,477 93,527 110,340 154,403 174,646 174,658
Reference price 2 0.5400 0.4700 0.2200 0.3565 0.1973 0.1381
Announcement Date 3/22/19 3/26/20 3/25/21 3/24/22 3/29/23 3/21/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1.824 0.742 1.544 1.535 0.95 1.039
EBITDA 1 -8.279 -8.832 -5.53 -7.191 -8.636 -8.725
EBIT 1 -8.998 -9.55 -6.264 -7.982 -9.413 -9.491
Operating Margin -493.31% -1,287.06% -405.7% -520% -990.84% -913.47%
Earnings before Tax (EBT) 1 -10.11 -10.66 -7.044 -9.318 -10.69 -9.927
Net income 1 -10.11 -10.66 -7.044 -9.312 -10.69 -9.927
Net margin -554.17% -1,436.66% -456.22% -606.64% -1,125.26% -955.44%
EPS 2 -0.1364 -0.1140 -0.0650 -0.0680 -0.0700 -0.0568
Free Cash Flow 1 -6.374 -5.398 -4.541 -3.998 -6.33 -2.602
FCF margin -349.47% -727.51% -294.12% -260.44% -666.29% -250.48%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/22/19 3/26/20 3/25/21 3/24/22 3/29/23 3/21/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 6.87 7.67 1.52 7.98 13.2
Net Cash position 1 3.04 - - - - -
Leverage (Debt/EBITDA) - -0.7783 x -1.388 x -0.2111 x -0.9245 x -1.515 x
Free Cash Flow 1 -6.37 -5.4 -4.54 -4 -6.33 -2.6
ROE (net income / shareholders' equity) -146% -207% 2,135% -638% -4,772% 127%
ROA (Net income/ Total Assets) -33.9% -38.5% -35.4% -34.4% -43.4% -67.9%
Assets 1 29.81 27.72 19.92 27.09 24.62 14.62
Book Value Per Share 2 0.1100 0 -0.0100 0.0300 -0.0200 -0.0700
Cash Flow per Share 2 0.0700 0.0100 0.0100 0.0300 0.0100 0.0100
Capex 1 1.1 0.53 0.12 0.11 0.27 0.18
Capex / Sales 60.09% 70.75% 7.77% 7.04% 28.53% 17.32%
Announcement Date 3/22/19 3/26/20 3/25/21 3/24/22 3/29/23 3/21/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.164
Average target price
-
Consensus
  1. Stock Market
  2. Equities
  3. IGXT Stock
  4. IGX Stock
  5. Financials IntelGenx Technologies Corp.